國家衛生研究院 NHRI:Item 3990099045/8205
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 859788      Online Users : 830
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/8205


    Title: Overexpression of DPP4 is a poor prognostic factor for patients with urothelial carcinoma of the upper urinary tract and urinary bladder
    Authors: Liang, PI;Wu, WJ;Huang, CN;Li, CC;Ke, HL;Li, WM;Yeh, HC;Li, CF;Lee, YY;Lin, HH;Yeh, BW;Hwang, SJ
    Contributors: National Institute of Cancer Research
    Abstract: Background:Dipeptidyl peptidase-4 (DPP4), also known as CD26, is an enzyme that cleaves a diversity of protein that contains proline or analine, including chemokines, growth factors, and neuropeptide. Different DPP4 expression status has been observed in malignant tumours, including colon, renal, and ovarian carcinoma. Data mining of the published dataset (GSE31684) identified that DPP4 is significantly upregulated in urothelial carcinoma of the urinary bladder. We therefore analysed the association of DPP4 expression and outcome in our well-characterised cohort of urothelial carcinoma. Methods: Laser capture microdissection coupled with real-time qRT-PCR was used to evaluate DPP4 transcript level in 20 urothelial carcinomas of the urinary bladder. DPP4 immunostaining was done on 340 cases of urothelial carcinoma of the upper urinary tract and 295 cases of urothelial carcinoma of the urinary bladder. The expression status of DPP4 was then correlated with various clincopathological factors, disease-specific survival (DSS), and metastasis-free survival (MeFS). Findings: DPP4 mRNA expression was significantly increased in urothelial carcinomas with higher pT status (p < 0.001). In both groups of urothelial carcinomas, increment of DPP4 immunoexpression was significantly associated with advanced pT stage (both p < 0.001), high histological grade (urothelial carcinoma of the upper urinary tract, p = 0.019), lymph node metastasis (urothelial carcinoma of the upper urinary tract,p < 0.001; urothelial carcinoma of the urinary bladder, p = 0.033), vascular invasion (both p < 0.001), perineurial invasion (urothelial carcinoma of the urinary bladder, p = 0.021) and frequent mitosis (urothelial carcinoma of the upper urinary tract, p = 0.003). DPP4 overexpression independently predicted poor DSS (urothelial carcinoma of the upper urinary tract, p = 0.028; urothelial carcinoma of the urinary bladder,p < 0.0001) and MeFS (urothelial carcinoma of the upper urinary tract, p = 0.031; urothelial carcinoma of the urinary bladder, p < 0.0001) in both groups of patients. Interpretation: Our study shows that overexpression of DPP4 is significantly associated with aggressive tumour behaviour and poor outcome. DPP4 may have an important role in tumorigenesis of urothelial carcinoma.
    Date: 2014-05
    Relation: European Journal of Cancer. 2014 May;50(Suppl. 4):e39.
    Link to: http://dx.doi.org/10.1016/j.ejca.2014.03.152
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0959-8049&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000351589200110
    Appears in Collections:[Others] Conference Papers/Meeting Abstract

    Files in This Item:

    File Description SizeFormat
    SDO0959804914004249.pdf35KbAdobe PDF517View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback